Bioventus Inc. Class A Common Stock BVS

$14.26 +2.66% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
8-K 8-K 2026-06-04 View →
8-K 8-K 2026-05-21 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
DEF 14A DEF 14A 2026-04-22 View →
4 FORM 4 2026-04-14 View →
4 FORM 4 2026-04-14 View →
4 FORM 4 2026-04-14 View →
4 FORM 4 2026-03-24 View →
4 FORM 4 2026-03-17 View →
4 FORM 4 2026-03-17 View →
4 FORM 4 2026-03-17 View →
4 FORM 4 2026-03-17 View →
4 FORM 4 2026-03-13 View →
10-K 10-K 2026-03-05 View →
8-K 8-K 2026-03-05 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-02-18 View →
4 FORM 4 2026-01-13 View →
4 FORM 4 2025-12-08 View →
8-K 8-K 2025-11-17 View →
4 FORM 4 2025-11-10 View →
10-Q 10-Q 2025-11-04 View →
8-K 8-K 2025-11-04 View →
10-Q 10-Q 2025-08-06 View →
8-K 8-K 2025-08-06 View →
8-K 8-K 2025-08-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$14.26
Market Cap
$1.20 billion
52-Week Range
$5.81 – $15.89
Average Volume
818K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.